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Two major elements underlie a thorough
understanding of the pathogenesis of virtually
any infectious disease: identification and
characterization of the virulence factors and in
vivo survival mechanisms of the invading
microorganism (e.g., surface attachment fac-
tors, exotoxins, or enzymes that disrupt cellular
homeostasis [1]) and understanding of the
components of the host response that lead to
elimination of the invading pathogen and
resolution of disease. (These include both
nonspecific [or innate] immune defense
mechanisms, such as the complement cascade,
and adaptive elements, such as clonally derived
lymphocytes capable of eliminating specific
targets [2]). The traditional approach to human
infectious diseases has been to focus research
on the study of important pathogens. The
outcome of investigation of relevant bacteria,
viruses, fungi, and parasites has led to the
production of protective vaccines, antimicrobial
agents, and effective strategies for control and
elimination of disease outbreaks. A principal
advantage of microbiologic research is the
relative ease with which the organisms may be
obtained, manipulated, and analyzed in the
laboratory. Because microbial genomes are
smaller, complete cloning and DNA sequencing of
several microorganisms have been achieved and
have paved the way for comprehensive study of
gene expression and genome organization (3,4). In
contrast are relatively limited advances in our
understanding of the molecular basis of host
defense. The study of host immune defense in
humans is inherently complex; obstacles to
greater understanding include limited opportuni-
ties for controlled observation and experimental
manipulation, a large genome, and until recently,
a lack of molecular techniques capable of
facilitating genomewide analysis.
Genetic Analysis
One of the principal aims of the study of host
response to infectious diseases is to uncover novel
components of the host immune system critical to
robust host defense. Identification of these
components at a molecular level is the first step in
understanding how the host deals with an
infectious challenge and lays a foundation upon
which rational therapies that augment host
resistance may someday be designed. Despite this
promise, the interaction between host and
The large size and complexity of the human genome have limited the identification
and functional characterization of components of the innate immune system that play a
critical role in front-line defense against invading microorganisms. However, advances
in genome analysis (including the development of comprehensive sets of informative
genetic markers, improved physical mapping methods, and novel techniques for
transcript identification) have reduced the obstacles to discovery of novel host
resistance genes. Study of the genomic organization and content of widely divergent
vertebrate species has shown a remarkable degree of evolutionary conservation and
enables meaningful cross-species comparison and analysis of newly discovered genes.
Application of comparative genomics to host resistance will rapidly expand our
understanding of human immune defense by facilitating the translation of knowledge
acquired through the study of model organisms. We review the rationale and resources
for comparative genomic analysis and describe three examples of host resistance
genes successfully identified by this approach.37 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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pathogen that leads to infection is multidimen-
sional, dynamic, and exceedingly complex. From
a genomic perspective, a thorough understand-
ing of the pathogenesis of a given infection would
include a complete inventory of the spatial and
temporal expression of the genes by both the host
and pathogen from the time of exposure to the
final resolution of the infection. Given the
potentially large number of factors that
contribute to host defense, precise gene
identification is a formidable challenge. Never-
theless, researchers have recently made progress
in dissecting and identifying the most important
individual genetic elements that govern the host
response to important pathogenslargely
through the use of animal models of human
disease (5). Of the model organisms amenable to
genetic analysis, the mouse is by far the most
well-developed and physiologically relevant
system for study of human host defense (6,7).
Identification of commercially available inbred
strains of mice that show a differential response
to a well-defined infectious challenge is the first
requirement for study of genetically regulated
host resistance factors. Once distinct phenotypes
are identified, controlled breeding is carried out
to determine the mode of inheritance of the
phenotype (simple or complex). Correlation of
the inheritance of susceptibility or resistance to a
specific infectious challenge with one or more
chromosomal regions is then performed by using
linkage analysis. Finally, known genes within
the genetic interval must be evaluated and novel
genes must be positionally cloned to elucidate
the underlying molecular basis of immune
defense. Comparative genomic analysis is a
logical extension of these principles (8).
Knowledge of the genomic organization of
human and mouse, for example, facilitates direct
localization and identification of the human
orthologues of susceptibility genes identified
through experimental challenge. These genes
can then be tested as candidates for human
disease susceptibility through mutation analysis.
Genetic Linkage Maps
Genetic linkage maps provide an organiza-
tional framework for genes and phenotypes in
the genome (9). Maps, by establishing the
location, order, and relative distance of genes,
anonymous DNA markers, and biologically
important traits along a species chromosomes,
are critical tools in analyzing genetic contribu-
tion to a given disease state. Genetic maps can
help precisely localize chromosomal region(s)
linked to host resistance phenotypes and provide
the starting point for identification of the
causative gene(s). During the past decade,
comprehensive genetic maps spanning the
genomes of mouse and human, have been created
largely through the initiative of the Human
Genome Project (10).
Mapping the Human Genome
A great deal of effort has resulted in the
creation of a whole genome human linkage map,
consisting of 5,624 microsatellite markers
located to 2,335 positions (11). The DNA markers
in this map are highly informative and are
densely distributed, with an average interval
between markers of 1.6 centimorgans (cM) (1 cM
= a 1% rate of recombination during meiosis, or
approximately 1 million bp). Other comprehen-
sive maps have been assembled on the basis of a
collection of more than 16,000 distinct tran-
scribed sequences (including known genes and
gene fragments) or expressed sequence tags,
which are estimated to represent at least 50% of
all genes in the human genome (12). This human
transcription map has been integrated with
selected microsatellite markers from the
Généthon collection, thus allowing the position
of gene-based markers to be resolved to specific
intervals measured in centimorgans. The map is
available electronically (13). Work is also under
way to generate comprehensive physical maps of
the human genome in which the relative location
of markers is defined by the actual length along
the chromosome, rather than by recombination
events (14,15).
Mapping the Mouse Genome
Among model organisms, genetic mapping is
most well established in the mouse, having
begun in 1915 with the discovery of the first
linkage group (16). Controlled crosses of common
laboratory strains segregating a small number of
visible phenotypes such as coat color then
became the mainstay of genetic mapping. In the
past decade, two major breakthroughs have
revolutionized the technique of mouse genetic
mapping and paved the way for generation of
high-resolution whole genome maps. The first
was the development of the interspecific cross,
involving a laboratory strain (Mus musculus)
and a distantly related species Mus spretus (17),38 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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Figure. Schematic representation of microsatellite
marker analysis in mice. A) Flanking forward (F) and
reverse (R) oligonucleotides are designed to
specifically amplify a simple sequence repeat by
polymerase chain reaction (PCR) (in this case a CA
dinucleotide). The length of the dinucleotide (N)
varies among inbred mouse strains. B) Gel
electrophoresis of a PCR-amplified microsatellite in
homozygous parental strains A and B and
heterozygous F1 progeny. The larger microsatellite
from strain A migrates more slowly than that of
strain B. Inheritance of both parental alleles is shown
in the F1.
allowing literally thousands of genes to be
mapped within the same cross. The second
advance was the development of abundant
genetic markers rapidly typable by polymerase
chain reaction (PCR) (termed microsatellites),
which amplified polymorphisms in simple
sequence length repeats such as [CA]n (Figure)
(18). Several comprehensive genetic maps of the
mouse (based on genes or microsatellites) have
been developed, and in some cases, these are
being integrated. At least three are publicly
available, while the others are available for
mapping in a collaborative arrangement (19). As
of January 1997, more than 17,000 markers had
been mapped in the mouse (one locus
approximately every 200kb), including more
than 5,000 genes and more than 10,000 (mostly
microsatellite) DNA markers.
Mapping in Other Species
Genetic mapping has been widely embraced
by the scientific community; more than 30
vertebrate species are the subject of genetic
mapping projects, and high-resolution maps of
microsatellite markers have been developed for
humans, mice, rats, cows, sheep, pigs, fish, and
chickens (19). Two invertebrates, Drosophila
melanogaster  (a dipteran fly) and Caenorhabditis
elegans (a nematode), also have complete genetic
and physical maps; the complete nucleotide
sequence of the latter is expected in the near
future. The status of individual genetic mapping
projects and resources has been summarized,
along with a compilation of databases for species-
specific or comparative mapping reference
(19,20). Integrating the data from these species-
specific projects in a form that allows relevant
information from diverse organisms to be
assembled is a major challenge to biologic
information systems. The most extensive
coverage of mammalian species homologies is the
Mouse Genome Database of The Jackson
Laboratory (21). Initially developed for the
mouse, comparative mapping data for more
than 55 species may be searched online, with
links to related genomic resources, such as the
Human Genome Database, Ratmap, SheepBase,
and PigBase.
Comparative Genetic Mapping
Because of the density of genetic markers
positioned along the chromosomes of both
organisms, the comparative map of the mouse
and human genomes is the most well developed
of all species. In a comprehensive summary of
mouse/human homology published in 1996,
1,416 loci were placed on both maps by using
human physical mapping data and mouse
genetic maps (22). This comparison defined 181
conserved linkage groups, approximately 90% of
the mouse genome. Further comparative mapping
with newly discovered genes and expressed
sequence tags will refine the chromosomal
relationships between mouse and human.
Integrating Maps and Aligning Genomes
The integration of existing genetic maps of
different species is a formidable challenge.39 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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Accurate, comprehensive comparisons of gene
arrangements across different species will
rapidly advance our understanding of all aspects
of biology by allowing rapid information
exchange across different model organisms and
experimental systems. Several approaches have
been used in developing universal mapping
probes for diverse genomes (23-25). Of the two
classes of loci used to construct gene maps,
coding gene sequences (Type I markers), which
show conservation among distantly related
mammalian species, are most useful as
landmarks for comparing linkage and syntenic
association. Highly polymorphic sequences
(Type II markers), such as microsatellites, are
more abundant and are invaluable for mapping
within a pedigree but are less useful for
comparative purposes because they do not show
adequate sequence conservation to recognize
locus homology between mammalian orders. In
1993, a list of anchored reference loci for
comparative genome mapping in mammals was
proposed; it consists of 321 Type I markers
equivalently spaced throughout the mammalian
genome (26). This approach allowed the position
of homologous loci in the maps of four species
(human, mouse, cattle, and cat), which represent
different mammalian orders, to be established.
Interspecies comparison of conserved exon
sequences of homologous genes has generated a
new overlapping set of anchor loci called
comparative anchor tagged sequences (25).
Large-scale mapping of these sequences in
several species may be an efficient way of
developing high-resolution comparative maps
with essentially complete genome coverage.
Alternative Techniques for Comparative
Genomic Analysis
Mammalian genomes may be compared at
several levels by using a variety of tools and
strategies tailored to individual objectives.
Although direct sequence comparison of whole
genomes will provide the highest resolution for
comparative study, this sophisticated form of
analysis is at least several years away from being
realized. At a cytologic level, species may be
compared by fluorescence in situ hybridization
(FISH) with single or multiple probes (single or
multicolor Zoo-FISH), producing rapid, high-
resolution chromosomal localization detectable
by microscopy. Alternatively, libraries from
microdissected or individual flow-sorted chromo-
somes may be constructed and used as
fluorescence-labeled chromosome paints to
probe the chromosomes of other species and
identify homologous regions (27,28). The main
advantage of chromosome painting is its rapid
overall evaluation of the extent and character of
genomic conservation among distantly related
species, such as pig and cattle. In contrast to
FISH, chromosome painting does not allow
determination of gene order or high-resolution
demarcation of chromosomal breakpoints. Ra-
diation hybrid panels, another method for
physical assignment of homologous loci (29,30),
are generated by irradiation and subsequent
fusion of a cell line containing a chromosome
from one species, such as human, on another
background, such as hamster. The donor DNA is
fragmented at random, resulting in a series of
lines retaining only fragments of the original
chromosome. Conserved genes from other
species may be mapped to the homologous region
of the human genome by comparing the PCR
pattern for each cell line to reference loci with
well-established map positions.
Models of Human Disease
Identifying genetically regulated host im-
mune responses might significantly advance our
understanding of the molecular targets and
immunologic mechanisms critical to robust
defense against pathogenic microbes. To date the
number of host defense genes that have been
cloned remains small; comparative genomics has
the potential to accelerate gene discovery by
allowing available data for model organisms to be
rapidly applied to the study of human disease.
We summarize three examples of human host
resistance genes in the following section; in each
example, genetic analysis of mouse models of the
human disease phenotype played a crucial role in
the initial discovery of the human homologue or
served as a means of validating the identity of
the proposed human candidate disease gene.
Nramp 1 and NRAMP1
The Mouse Nramp1 Gene
In classic inbred strains of mice, natural
resistance to infection with Mycobacterium
bovis (BCG), M. lepraemurium, Salmonella
Typhimurium, and Leishmania donovani is
controlled by the Bcg locus, also known as Ity and
Lsh (31-33). The major effect of the Bcg gene is to40 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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modulate the growth rate of these diverse
pathogens in cells of the reticuloendothelial
system of the mouse during the preimmune
phase of the infection (33). Resistant and
susceptible strains are distinguished by the
kinetics of infection shown by pathogen counts
(CFUs or Leishmania-forming units) in liver and
spleen after infection. The susceptible phenotype
is characterized by a higher net growth rate of
BCG, Salmonella, or Leishmania in the
reticuloendothelial system during the early
phase of infection, followed by specific immune
responses in BCG- and L. donovaniinfected
mice or by a rapidly lethal infection with the
virulent pathogen S. Typhimurium. Bcg is
inherited as a simple autosomal dominant
Mendelian trait in crosses between classical
strains of laboratory mice; it was localized to
mouse chromosome 1 by linkage analysis (34).
Using a positional cloning strategy, Vidal et al.
(35) isolated the Nramp1 (natural resistance-
associated macrophage protein 1) gene as a
strong candidate for the Bcg mutation based on
its map location, its macrophage-restricted
expression pattern and a nonconservative
Gly169Asp substitution in the protein of all
susceptible strains. Creation of a null allele at
Nramp1 then provided formal proof that a
mutation within Nramp1 is the cause of the
mouse susceptibility to infection with M. bovis,
S. Typhimurium, and L. donovani (36).
Nramp1, an integral membrane
phosphoglycoprotein located in the late endo-
some/lysosome compartment of resting macroph-
ages, is recruited to the maturing phagosomal
membrane (37), consistent with its potential
function in controlling the replication of
intracellular parasites by altering the
intravacuolar environment in which they reside.
Nramp1 is part of an ancient family of proteins
with highly conserved members in mammals
(including humans, cows, rats, sheep), birds,
invertebrates (C. elegans, D. melanogaster),
plants (Oryza sativa, Arabidopsis thaliana),
fungi (Saccharomyces cerevisiae), and even
bacteria (M. leprae and Escherichia coli) (38,39).
This family is characterized by a highly
conserved hydrophobic core consisting of 10
transmembrane (TM) domains with a structural
organization typical of families of ion transport-
ers and channels. In addition, the most highly
conserved segments of the Nramp family (TM8-
TM9 intracellular loop) show impressive similar-
ity with the highly conserved region of
mammalian voltage-gated K+ channels of the
shaker type (40).
Several issues concerning the biochemical
function of Nramp1 with respect to intracellular
survival of taxonomically unrelated pathogens
remain unresolved. Studies of the function of
Nramp1-related sequences (Nramp2 and Smf1
in model organisms) provide insight into how
Nramp1 confers resistance to microbial agents.
Nramp2 has been isolated in mouse and human
and shows a high degree of similarity to Nramp1
(77% overall similarity), with identical hydropa-
thy profiles and predicted secondary structures
(41,42). Mouse and human Nramp2 mRNA are
both widely expressed in contrast with the
tissue-specific expression of Nramp1 (41, 42).
Recently, Nramp2 was shown to be a metal ion
transporter with broad divalent cation specificity
(including Fe2+, Zn2+, Mn2+, Co2+, Cd2+, Cu2+,
Ni2+, and Pb2+), driven by the proton electro-
chemical gradient in Xenopus laevis oocytes (43).
Studies using the yeast double mutant SMF1/
SMF2 provided additional support concerning
the function of Nramp2 as a divalent cation
transporter. Inactivation of SMF1 and SMF2,
two yeast Nramp homologues encoding divalent
cation transporters (44), is specifically comple-
mented by Nramp2 (45). In vivo, Nramp2 plays
an important role in normal iron transport.
Mutation within Nramp2 causes microcytic
anemia in mk mutant mice because of severe
defects in intestinal iron uptake (46). Interest-
ingly, the missense mutations in mutant
Nramp1 and Nramp2 alleles introduce a charged
amino acid in two adjacent positions of TM4,
confirming the importance of this region of both
proteins for normal function. It has been
suggested that Nramp1 may also be a divalent
cation transporter; its role in reticuloendothelial
cells remains unexplored (40,44).
The Chicken NRAMP1 Gene
The discovery of Nramp1 allowed the study
of its role in susceptibility to related infections in
other species. Salmonellosis, one of the most
common causes of food poisoning in humans, is
frequently caused by ingestion of contaminated
poultry products; efforts to identify salmonella
resistance genes in poultry could lead to more
efficient poultry control strategies, thereby
reducing secondary human morbidity. Genetic
regulation of chicken host resistance exists, as41 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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inbred poultry lines differ in their susceptibility
to infection with several strains of Salmonella.
Segregation analysis with a combination of
Salmonella-resistant and Salmonella-suscep-
tible lines has shown that resistance to infection
is fully dominant and is not sex-linked or
associated with the major histocompatibility
complex (47). The candidacy of the chicken
Nramp1  homologue was tested in the differential
resistance of inbred chicken lines to infection
with S. Typhimurium by using sequencing and
linkage analyses (48). Through the use of a
mouse cDNA, the chicken homologue Nramp1
has been cloned and shown to share 68% identity
with the mouse gene (49). As demonstrated in
mice, the macrophage is a major site of NRAMP1
mRNA expression in chickens (49). NRAMP1
mRNA transcripts from S. Typhimurium
resistant or susceptible chickens were analyzed
to identify amino acid sequence variants that
could be associated with the disease phenotype.
Eleven sequence variants in Nramp1 mRNA
were obtained from three Salmonella-resistant
and three Salmonella-susceptible chicken lines;
almost all (10) resulted in silent mutations or
conservative changes (to amino acids with
similar physical properties) that were detected
both in resistant and susceptible chicken lines,
while only one sequence variant resulted in a
non-conservative substitution of a positively
charged residue (Arg223 by a polar residue
(Gln223). This allelic variant was specific to the
susceptible line C and was clearly associated
with survival to infection (a resistance allele at
NRAMP1 improved survival rate from 13% to
27%) (48). Taken together, these data strongly
suggest a direct role of NRAMP1 in susceptibility
to infection in chickens.
The Human NRAMP1 Gene
Work in inbred strains of mice has
established unambiguously that Nramp1 has an
important role in determining resistance to
mycobacterial infections and has encouraged
several research groups to test the association of
NRAMP1 with corresponding human infections.
Host genetic factors play a major role in
determining the outcome of mycobacterial
infections in humans, as shown by racial
variation in susceptibility to infection and higher
concordance of tuberculosis and leprosy among
monozygotic twins compared with dizygotic
twins and siblings (50,51). Segregation analysis
in a population from Desirade Island (French
West Indies) has demonstrated that susceptibil-
ity to leprosy (regardless of the clinically defined
subtype) is controlled by a major gene not linked
to the major histocompatibility complex (52).
Through use of a candidate gene approach,
population association studies, and linkage
analysis, several genes (HLA-linked genes,
tumor necrosis factor, collectin, vitamin D
receptor, interferon gamma receptor) have each
been associated with susceptibility to mycobacte-
rial infections (53,54).
The chromosomal region surrounding
Nramp1 on mouse chromosome 1 has been
conserved on the telomeric end of human
chromosome 2q35 and contains the human
NRAMP1 orthologue (55). Sequence comparison
of the mouse and human Nramp1/NRAMP1
proteins showed a high degree of conservation
between the two species (85% identity, 92%
similarity); the most conserved region was the
intracellular loop containing the consensus
sequence transport motif (56). In humans, the
highest sites of NRAMP1 expression are
peripheral blood leukocytes and lungs (56). The
high degree of sequence homology between
mouse and human NRAMP1, the presence of
similar regulatory elements within the promoter
regions of the genes, and similar tissue
expression patterns support the notion that the
NRAMP1 protein exerts similar roles in vivo in
both mouse and humans.
A number of polymorphic variants have been
used to study the association of NRAMP1 and
susceptibility to leprosy and tuberculosis (57-60).
One study based on the segregation analysis of
certain  NRAMP1 haplotypes in 20 multiplex
families involving 168 individuals from South
Vietnam clearly showed that NRAMP1 was
involved in predisposition to leprosy (61).
Another large study measuring the association of
NRAMP1 with clinical tuberculosis in a
population of Gambia (West Africa) demon-
strated that polymorphic variations within the
human  NRAMP1 gene affect susceptibility to the
disease (62). Nevertheless, susceptibility to
either leprosy or tuberculosis appears to be
genetically heterogeneous since the role of
NRAMP1 was observed only in certain ethnic
groups (63,64).
Identification of Nramp1 illustrates the
value of comparative genomics for identification
and characterization of the biologic basis for42 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
Synopses
differences between susceptible and resistant
hosts. Genetic dissection of the mouse model of
M. bovis infection was crucial to the identifica-
tion of similar mechanisms governing the human
response to medically important pathogens such
as tuberculosis and leprosy. Comparative
genomics was also important in accelerating the
identification of an important host resistance
gene for salmonellosis in the chicken (a species of
significant agricultural importance), where the
available genetic tools are modest, relative to
mice and humans.
Chediak-Higashi Syndrome (CHS)
CHS is a rare autosomal recessive disorder
characterized by partial ocular and cutaneous
albinism, a mild bleeding diathesis, and
peripheral sensorimotor neuropathy. The most
serious phenotype among CHS patients, how-
ever, is a marked increased in susceptibility to
bacterial infection that may lead to death during
the first 2 decades of life. These clinical features
are attributable to dysfunctional granule-
containing cells including melanocytes, plate-
lets, Schwann cells, neurons, and granulocytes
(65,66). On the basis of phenotypic similarity, the
beige ( bg) mutation in mice has long been
regarded as a model for CHS (67). Several
components of the immune system are affected
in  Beige/CHS. Neutrophils exhibit defective
chemotaxis and reduced intracellular killing for
up to 90 minutes after bacterial phagocytosis,
and their granules lack the serine proteases
cathepsin G and elastase because of a failure of
normal protein sorting (68,69). Natural killer cell
activity is defective, causing impaired cytolysis
of tumors and virally infected cells; cytotoxic
T-cell responses against allogeneic tumor cells
are also abnormal (70,71). Mice with the bg
mutation have increased susceptibility to a
variety of pathogens, including cytomegalovirus,
Leishmania donovani, Candida albicans, and a
variety of pathogenic bacteria (E. coli, Klebsiella
pneumoniae, Staphylococcus aureus, Streptococ-
cus pneumoniae) (72-74).
To identify the genetic basis of this host
resistance defect, the bg gene was localized to a
0.24 cM interval of proximal mouse chromosome
13 by genetic mapping of three mouse back-
crosses segregating this phenotype (75). A DNA
contig of this region spanning 2,400 kb was
constructed from large-capacity yeast artificial
chromosomes and P1 bacteriophage clones (76).
Using yeast artificial chromosome complementa-
tion and direct cDNA selection, two groups
subsequently identified portions of a candidate
gene for bg, named Lyst (lysosomal trafficking
regulator) (77,78). Lyst, ubiquitously expressed
in the mouse, has a maximum transcript size of
approximately 12kb and possible complex
alternative splicing. Several mutations pre-
dicted to severely truncate the Lyst polypeptide
were identified within each transcript. Through
the use of partial sequence data for mouse Lyst,
27 cDNAs corresponding to the human gene
were identified and assembled into a complete
human gene sequence of 13,499 bp, with an open
reading frame of 11,403 bp (79). Comparison of
the partial 3' mouse cDNA to the human
sequence demonstrated 77.2% nucleotide iden-
tity and 87.9% amino acid identity, indicating
that human and mouse genes are highly
homologous, and sequence analysis of three CHS
patients identified pathologic mutations in all.
Comparative genetic mapping between the
region of mouse chromosome 13 with the bg
mutation and the human genome indicates
homology with distal chromosome 1q. Consistent
with this alignment, genetic mapping of the
human CHS locus in affected families localized it
to 1q42-1q44 as part of a conserved linkage group
shared with mouse chromosome 13 (80,81).
Radiation hybrid mapping also assigned the
human CHS candidate gene to 1q43, confirming
that the bg phenotype in mouse and human CHS
are both caused by mutations in orthologous
genes (79). Database searches with the complete
nucleotide sequence of the CHS gene showed
significant homology to open reading frames
from  S. cerevisiae and C. elegans, as well as a
human cell division control protein-4 (CDC4L)
(82). The modular architecture of the CHS
protein is similar to Vps15, a yeast serine/
threonine kinase protein kinase thought to be
part of a membrane-associated signal transduc-
tion complex regulating intracellular protein
trafficking (83). To date, the function of the CHS
gene remains unknown, although it may be similar
to Vps15 and may be part of a novel gene family.
X-Linked Agammaglobulinemia (XLA)
XLA, one of the first primary immunodefi-
ciency disorders described in humans, is the
prototypic example of the protective role of
humoral immunity against common bacterial
pathogens (84). XLA is characterized by a43 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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profound deficiency of B-lymphocyte develop-
ment at two sequential stages of maturation
within the bone marrow (85). This defect results
in marked reductions in the serum levels of all
three major classes of immunoglobulins and a
profound decrease in the number of B lymphocytes
in the peripheral blood as well as in the lymphoid
follicles and germinal centers of lymph nodes.
The clinical manifestations generally begin by
the end of the first year of life, once the level of
maternally derived antibodies has declined.
Bacterial infections with organisms such as
S. pneumoniae, Haemophilus influenzae,
S. aureus, and Pseudomonas species are most
common, with the respiratory tract being most
frequently affected. Gastrointestinal infection
with Salmonella or Campylobacter have also
been reported, as have urogenital infections with
Mycoplasma or Chlamydia. XLA patients have
defective host resistance to enteroviruses, since
neutralizing antibody is important in controlling
these pathogens during their passage through
the blood stream. Resistance to other infections
for which intact T lymphocyte function is
required (e.g., tuberculosis or histoplasmosis)
remains intact.
Recognition of the familial occurence of this
rare disorder and pedigree analysis demon-
strated an X-linked recessive inheritance
pattern of the trait (86). Carrier females could
not be detected because they are phenotypically
normal, with normal serum levels of immunoglo-
bulin. Linkage studies of over 500 individuals
from 60 families mapped the gene for XLA to the
midportion (Xq22) of the X chromosome,
cosegregating with the polymorphic genetic
marker DXS178 (87,88). By using complemen-
tary strategies of positional cloning and low-
stringency cDNA library screening, two groups
identified a novel src-like cytoplasmic tyrosine
kinase, named Btk (Bruton agammaglobuline-
mia tyrosine kinase) as a strong candidate gene
for XLA (89, 90). Btk was mapped to the XLA
locus by FISH and somatic cell hybrid analysis
and was expressed in cell lines representing all
stages of B cell development, myelomonocytic
cell lines, and a macrophage cell line; it was not
detectable in T lineage cell lines (90). In
transformed B-cell lines from individuals
affected with XLA, the expression level of Btk
mRNA and protein, and consequently its kinase
activity, was reduced or absent. Southern blot
analysis of DNA from pedigrees with XLA cases
showed restriction fragment length alterations
that segregated in an X-linked recessive pattern;
detailed analysis disclosed either genomic DNA
deletions in the region encompassing Btk or
missense point mutations resulting in
nonconservative amino acid substitutions at
important residues in the putative protein-
tyrosine kinase domain (89). These findings
provide strong evidence that the failure of
normal B-cell growth and differentiation in XLA
is caused by abnormal function of an intracellu-
lar protein tyrosine kinase.
The CBA/N inbred mouse strains X-linked
immunodeficiency (xid) has been regarded as an
experimental model for human XLA since it was
first described in 1972 (91). B lymphocytes from
these mice exhibit pleiotropic defects in
development and function. Normal numbers of
pro-B, pre-B, and surface immunoglobulin-
positive B cells exist in the bone marrow, while
peripheral B-cell numbers are significantly
reduced (30% of normal). The B lymphocytes that
are present have an abnormal surface marker
phenotype, and B-cell proliferation triggered
through the surface immunoglobulin M (IgM)
receptor or surface immunoglobulin cross-
linking is impaired, as are responses to a number
of other mitogenic stimuli including lipopolysac-
charide, interleukins IL-5 and IL-10, CD38
receptors, and CD40 ligands. Consistent with
these defects, CBA/N mice have reduced serum
IgM and IgG3 antibody levels and cannot make
antibody responses when challenged with type-2
thymus-independent antigens (e.g., polysaccha-
rides and hapten-polysaccharide conjugates). As
with human XLA, impaired humoral immunity
can result in increased susceptibility to bacterial
pathogens, including S. Typhimurium (92).
Inheritance of the susceptibility trait was linked
to the xid locus by using back-cross and F2
progeny derived from crosses of CBA/N and
DBA/2N parental strains.
To determine whether XLA and xid were
caused by mutations in homologous genes, two
groups performed genetic mapping of xid and
Btk. The Btk gene was closely linked to the xid
locus in the distal region of the mouse
X chromosome by using an interspecific back-
cross mapping panel (93), and precise co-
localization of Btk and xid was observed in 1,114
segregating back-cross progeny (94). Normal and
mutant mouse strains did not differ in Btk
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analysis of the mouse Btk transcript in CBA/N
and several immunocompetent mouse strains
(including the CBA/CaHN progenitor) demon-
strated a point mutation within the first coding
exon that is predicted to convert a highly
conserved arginine residue to cysteine. This
amino acid substitution occurs within the
pleckstrin homology domain in the amino-
terminal region of the protein and is presumed to
alter normal B-cell signaling by disrupting
protein-protein interactions. To unequivocally
confirm that mutations in Btk were responsible
for the xid phenotype, targeted gene disruption
(a gene knockout experiment) was performed in
embryonic stem cells (95,96). Complete elimina-
tion of Btk protein production identically
reproduced the xid phenotype, indicating that
the naturally occurring point mutation produces
a complete loss-of-function phenotype or results
in a protein with dominant negative properties
(presence of a single mutant allele is sufficient to
block normal gene function). The severe early B-
lymphocyte developmental arrest of human XLA
was not observed, which suggests that Btk
function in mice is accompanied by a compensatory
mechanism operating during early B-cell
development to rescue B-cell maturation.
On the basis of comparative mapping and
sequence analysis, human XLA and the mouse
xid phenotype are clearly homologous disorders
caused by mutations in orthologous genes.
Nevertheless, although the underlying genetic
alteration in both species was successfully
identified, a number of issues remain unre-
solved. First, the phenotypes observed in these
two disorders are not identical; the more severe
block of early lymphocyte development in XLA
results in a greater deficiency of peripheral B
cells relative to the CBA/N mouse strain,
suggesting that the requirement for Btk in early
murine B-cell development is less stringent than
that for humans. Second, the range of pathogens
to which humans are are highly susceptible
appears more diverse than the range for mice.
Finally, the exact role of Btk in normal B-cell
physiology remains to be demonstrated. Thus far,
identification of BTK has led to carrier detection
and prenatal counselling; additional character-
ization of a mouse model with great similarity to
the human condition could advance our under-
standing of the fundamental processes underlying
B-lymphocyte development and function.
Conclusions
Complete understanding of infectious dis-
ease pathogenesis requires identification and
characterization of host genes that regulate the
response to virulent microorganisms. Through
evolutionary selection, a series of innate immune
defense mechanisms have evolved to protect the
host against the constant threat of microbial
injury and direct the development of specific
adaptive immune responses. Genetic analysis of
naturally occurring variation in the host
response among model organisms has success-
fully identified novel genes such as Nramp1,
Lyst, and Btk, thus providing new insights into
the molecular nature of host resistance. Rapid
advances are now being made in the creation and
integration of dense genetic maps of model
organisms and humans. Comparative genomics
will play an increasingly important role in
facilitating the transfer of new knowledge from
experimental models to a more complete
understanding of human host resistance.
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